198 related articles for article (PubMed ID: 18211896)
1. Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.
Hastie C; Masters JR; Moss SE; Naaby-Hansen S
J Biol Chem; 2008 May; 283(18):12595-603. PubMed ID: 18211896
[TBL] [Abstract][Full Text] [Related]
2. [Interferon-gamma decreases the adhesiveness and invasiveness of prostate cancer cells].
Gao L; Yang DJ; Lin XG; Xu WH; Wang XM
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):513-6. PubMed ID: 18649748
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the annexin family protein family is associated with prostate cancer progression.
Xin W; Rhodes DR; Ingold C; Chinnaiyan AM; Rubin MA
Am J Pathol; 2003 Jan; 162(1):255-61. PubMed ID: 12507908
[TBL] [Abstract][Full Text] [Related]
4. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis.
Fang YT; Lin CF; Wang CY; Anderson R; Lin YS
J Cell Physiol; 2012 Jun; 227(6):2775-87. PubMed ID: 21928315
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
9. Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.
Gopalakrishnapillai A; Kolb EA; Dhanan P; Mason RW; Napper A; Barwe SP
PLoS One; 2015; 10(10):e0140564. PubMed ID: 26465153
[TBL] [Abstract][Full Text] [Related]
10. IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.
Lo UG; Pong RC; Yang D; Gandee L; Hernandez E; Dang A; Lin CJ; Santoyo J; Ma S; Sonavane R; Huang J; Tseng SF; Moro L; Arbini AA; Kapur P; Raj GV; He D; Lai CH; Lin H; Hsieh JT
Cancer Res; 2019 Mar; 79(6):1098-1112. PubMed ID: 30504123
[TBL] [Abstract][Full Text] [Related]
11. INPP4B suppresses prostate cancer cell invasion.
Hodgson MC; Deryugina EI; Suarez E; Lopez SM; Lin D; Xue H; Gorlov IP; Wang Y; Agoulnik IU
Cell Commun Signal; 2014 Sep; 12():61. PubMed ID: 25248616
[TBL] [Abstract][Full Text] [Related]
12. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
Wu Q; Dhir R; Wells A
Mol Cancer; 2012 Jan; 11():3. PubMed ID: 22236567
[TBL] [Abstract][Full Text] [Related]
13. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
14. IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential.
Hobeika AC; Etienne W; Cruz PE; Subramaniam PS; Johnson HM
Int J Cancer; 1998 Jul; 77(1):138-45. PubMed ID: 9639405
[TBL] [Abstract][Full Text] [Related]
15. The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death.
Mebratu YA; Dickey BF; Evans C; Tesfaigzi Y
J Cell Biol; 2008 Nov; 183(3):429-39. PubMed ID: 18981230
[TBL] [Abstract][Full Text] [Related]
16. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism.
Sekine Y; Demosky SJ; Stonik JA; Furuya Y; Koike H; Suzuki K; Remaley AT
Mol Cancer Res; 2010 Sep; 8(9):1284-94. PubMed ID: 20671065
[TBL] [Abstract][Full Text] [Related]
18. Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II.
Liu J; Rothermund CA; Ayala-Sanmartin J; Vishwanatha JK
BMC Biochem; 2003 Sep; 4():10. PubMed ID: 12962548
[TBL] [Abstract][Full Text] [Related]
19. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
[TBL] [Abstract][Full Text] [Related]
20. Cellular interactions in the tropism of prostate cancer to bone.
Sikes RA; Nicholson BE; Koeneman KS; Edlund NM; Bissonette EA; Bradley MJ; Thalmann GN; Cecchini MG; Pienta KJ; Chung LW
Int J Cancer; 2004 Jul; 110(4):497-503. PubMed ID: 15122581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
